Vaccine effectiveness of 99.3% in individuals fully inoculated: Mandaviya

Vaccine effectiveness of 99.3 per cent has been seen in individuals fully inoculated against coronavirus according to the data uploaded on India COVID-19 Tracker till January 2

vaccine
Press Trust of India New Delhi
2 min read Last Updated : Feb 04 2022 | 8:09 PM IST

Vaccine effectiveness of 99.3 per cent has been seen in individuals fully inoculated against coronavirus according to the data uploaded on India COVID-19 Tracker till January 2, the Lok Sabha was told on Friday.

Responding to a question, Union Health Minister Mansukh Mandaviya said the Indian Council of Medical Research (ICMR) has developed the India COVID-19 Vaccine Tracker, by merging mainly three national databases -- CoWIN, National COVID-19 Testing database and COVID-19 India portal.

The tracker depicts vaccine effectiveness against death -- the ability of vaccines to reduce death -- using person time analysis from April 12, 2021 to January 2, 2022.

"The tracker is updated periodically and displays the effectiveness of partial and full vaccination against COVID-19.

"The latest data analysed and uploaded till January 2, 2022 depicts vaccine effectiveness of 99.3 per cent in fully vaccinated individuals against COVID-19," Mandaviya said in a written reply.

The data is analysed and presented as per the reports submitted by respective state governments.

Omicron variant is the dominant variant in the country presently. Whole genome sequencing for Omicron variant is done for all RTPCR positive samples from international travellers arriving since November 28, 2021. Further, for in-country sequencing RT-PCR positive samples having CT-value of less than 25 are referred from sentinel sites in various states regularly, Mandaviya said.

The Government of India is supporting states in their endeavour to manage COVID-19 since the beginning of pandemic. Given the emergence of mutated variants with variable impact on transmissibility, virulence and effectiveness of vaccines, likelihood of resurgence of COVID-19 trajectory in the country is monitored by various expert committees under Indian Council of Medical Research, Directorate General of Health Services and other relevant Ministries/Departments, he said.

The Union Ministry of Health and Family Welfare continues to keep a close watch over COVID-19 situation across the country and globally, the minister said.

The Ministry of Health vide letter dated June 28, 2021 has circulated to all states and Union Territories guiding principles for imposition of restrictions or allowing relaxation in context of coronavirus based on COVID-19 testing confirmation rates and hospital bed occupancy rates.

This has been reiterated by Ministry of Home Affairs under Disaster Management Act, 2005 vide order dated June 29, 2021, Mandaviya said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusMansukh Lal MandaviyaHealth MinistryCoronavirus Vaccine

First Published: Feb 04 2022 | 8:09 PM IST

Next Story